로고

  • HOME
  • SITEMAP
  • kOREAN
Home > Company Profile > Company Overview

Seoul Pharma Co., Ltd., (the “SPC”) has engaged in manufacturing and distribution of pharmaceuticals since its
establishment in 1976 and established the Centralized R&D Centre in 1997 for the purpose of R&D on new drug delivery
technology.

SPC’s sales revenue reached to KR\43.8Billion in 2014, showing more than 2% of CAGR for the past five years, when
comparing its KR\40.4Billion in 2010. SPC has produced more than 50 oral solid products mainly as Rx with such
therapeutic categories as respiratory, infective, cardio-vascular, gastro-intestinal, endocrinal, anti-obesity, and so on.
Throughout the 24 branch offices in Korea, SPC’s distribution activity has mainly been focused on clinic market,
having the products of SEBRON(anti-tussive, acetylcysteine), TORHES-F(digestive, trimebutine), DUVELAC(probiotics),
AUCLATIN (antibiotic, amoxicillin and potassium clavulanate), DIFLU(antifungal, fluconazole), EXLIP ER(dyslipidemic,
nicotinic acid), and so on. SPC was designated as a Venture company in 2000 and listed on the KOSDAQ, then in 2002
and 2003, and selected as a Promising export and INNO-BIZ company by Korean government authorities respectively.
Based on more advanced technology and accelerating R&D activities with number of R&D Pipeline including NME, IMD,
and so on, SPC has developed and launched many IMD products, such as “EXLIP ER” of hyperlipidemic agent as
extended-released type in 2006 and amino-acids supplementary suspension “ALIVER” in 2012.

In order to become a world-class pharmaceutical company, SPC has focused its R&D on the innovative and creative DDS
technology such as special formulations development and as its result, SPC developed a new Platform technology, named as “SmartFilm® Technology”, to produce Orally Disintegrating Film(ODF) products. SPC has planned to penetrate the
global market through SmartFilm® Technology with a new cGMP/EU-GMP plant was built in Osong city, especially
targeting to the US, EU, and other regulatory markets. Through SmartFilm® Technology, SPC is willing to enter the global
challenge for the market and be a Hidden Champion in the global pharmaceutical industry.